The transmissible spongiform encephalopathies (TSEs), or ' prion ' diseases, are neurodegenerative disorders which include Creutzfeldt-Jakob disease (CJD) and kuru in humans, bovine spongiform encephalopathy (BSE), transmissible mink encephalopathy, chronic wasting disease (CWD) in mule deer and elk, and scrapie in sheep and goats. Replication of the infectious TSE agent depends critically on the host prion protein (PrP c ), which accumulates as an abnormal, detergentinsoluble, relatively proteinase-resistant isoform, PrP Sc , in diseased tissues (Bolton et al., 1982 ; Bueler et al., 1992). The
precise nature of the infectious agent is uncertain, but PrP Sc copurifies with infectivity and is considered to be a major component (Farquhar et al., 1998 ; Prusiner et al., 1982) .
The consumption of BSE-contaminated meat products is the most likely cause of variant (v) CJD in humans (Bruce et al., 1997 ; Hill et al., 1997) , and ingestion has been implicated in the transmission of other TSE diseases. The timing of events in TSE pathogenesis, as determined by tracking PrP Sc accumulation, varies depending on agent strain, host genotype and the route of infection (Farquhar et al., 1994 (Farquhar et al., , 1996 . However, soon after experimental intragastric or oral exposure of rodents with scrapie, infectivity and PrP Sc accumulate first in Peyer's patches, gut-associated lymphoid tissues and ganglia of the enteric nervous system (Beekes & McBride, 2000 ; Kimberlin & Walker, 1989) , long before their detection in the central nervous system (CNS). Likewise, following experimental oral exposure of mule deer fawns with CWD, PrP Sc is also detected first in lymphoid tissues draining the gastro-intestinal tract (Sigurdson et al., 1999) . How and when sheep become infected with natural scrapie is not known, but the detection of PrP Sc in Peyer's patches and gut-associated lymphoid tissues (Andre! oletti et al., 2000 ; Heggebø et al., 2000) prior to detection within the CNS (van Keulen et al., 1999) suggests that this disease is also acquired orally.
Early PrP Sc accumulation takes place on follicular dendritic cells (FDCs) within germinal centres in lymphoid tissues of patients with vCJD (Hill et al., 1999) , sheep with natural scrapie (van Keulen et al., 1996) and rodents inoculated with scrapie by peripheral routes (Brown et al., 1999 ; Mabbott et al., 2000b ; McBride et al., 1992) . In mouse scrapie models, mature FDCs are critical for scrapie replication and PrP Sc accumulation in lymphoid tissues, and in their absence neuroinvasion following peripheral challenge is significantly impaired (Brown et al., 1999 ; Mabbott et al., 2000a, b ; Montrasio et al., 2000) .
The transport mechanisms by which TSE agents reach the germinal centres from the gut lumen are not known. Migratory bone marrow-derived dendritic cells (DCs) are centrally involved in transport of proteins both within Peyer's patches and on into mesenteric lymph nodes (Banchereau et al., 2000) . These cells are a distinct lineage from FDCs, which are tissueresident and are not considered to be of haemopoietic origin (Endres et al., 1999 ; Kapasi et al., 1993 wall from the bloodstream, sample antigens from the gut lumen, and then migrate via lymph to mesenteric lymph nodes (Liu & MacPherson, 1993) . These observations suggested to us that migrating DCs might provide a cellular bridge between the gut lumen and the secondary lymphoid tissues in which TSE agents replicate.
To test the hypothesis that DCs can acquire TSE agents, we first investigated the uptake of PrP Sc by DCs in vitro. Rat bone marrow-derived DCs (BMDCs) were prepared as previously described (Huang et al., 2000) and cultured at 1i10' cells\ml in RPMI 1640 medium supplemented with 2 mM -glutamine, 1 mM sodium pyruvate, 40 ng\ml murine GM-CSF and 1500 U\ml rat IL-4. Medium and cytokines were replaced every 72 h, and by day 10 to 12 of culture 90 % of cells had characteristic DC morphology and expressed MHC class II, B7 and CD11c. Scrapie-associated fibrils (SAF), highly infective fibrillar aggregates of PrP Sc , were prepared from the brains of mice terminally affected with the mouse-passaged ME7 strain as previously described (Hope et al., 1986) , sonicated in PBS, and a suspension equivalent to 10 mg infected brain tissue (wet weight) was added to each BMDC culture for the times indicated. Following incubation, culture medium was aspirated and cells lysed with 0n1% N-laurylsarcosine. Lysates were treated in the presence or absence of 50 µg proteinase K for 30 min at 37 mC, subjected to electrophoresis through 12 % SDS-polyacrylamide gels (Bio-Rad) and proteins transferred to polyvinylidine difluoride membranes (Bio-Rad). PrP was detected with rabbit polyclonal antiserum 1B3 specific for PrP (Farquhar et al., 1989) and bound antibody visualized by enhanced chemiluminescence (Amersham).
Detergent-insoluble, relatively proteinase K-resistant PrP Sc accumulations were detected in BMDC lysates within 3 h of culture with SAF, peaking at around 6 h of culture (Fig. 1) . No PrP Sc accumulations were detected at any time in lysates from BMDCs treated with PBS ( Fig. 1) or SAF equivalent preparation from normal uninfected brain (data not shown). Neither was uptake identified when B or T lymphocytes were incubated with SAF in vitro (data not shown). After antigen acquisition by DCs, a large proportion is degraded in endosomal\lysosomal compartments for presentation to T lymphocytes on MHC class II (Banchereau et al., 2000) . We have shown, however, that DCs, unlike macrophages, can retain some protein antigens in native, non-degraded form for at least 36 h (Wykes et al., 1998) . After 24 h of culture of BMDCs with SAF, the level of PrP Sc detected had declined moderately (Fig. 1) , implying that BMDCs acquire PrP Sc , some of which is subsequently catabolized but a considerable proportion of which is retained intact. An increased proteinase K-sensitive PrP signal was also detected after 24 h incubation (Fig. 1) , which may also represent the break-up of SAF aggregates within the DC and the revealing of more epitopes as the PrP is digested.
We next sought to demonstrate whether DCs can acquire and transport PrP Sc in vivo to mesenteric lymph nodes after delivery of SAF by intra-intestinal injection. PVG (RT1 c ) rats bred and maintained under specific-pathogen-free conditions were mesenteric lymphadenectomized as previously described (Liu et al., 1998 ; Pugh et al., 1983) . Six weeks later, when the afferent lymphatics (lacteals) draining the intestine had joined the efferent mesenteric lymphatics, SAF (equivalent to 10 mg infected brain tissue per rat) or PBS (as a control) was injected into the jejunum. Cells that would normally have been trapped in the mesenteric lymph nodes in intact animals were then collected by thoracic duct cannulation over 8 to 16 h. Lymph DCs ( 90 % pure) were isolated by a combined density centrifugation and magnetic antibody cell sorting protocol as previously described (Huang et al., 2000) , while T and B lymphocytes ( 99 % pure) were isolated by magnetic antibody cell sorting alone.
Immunocytochemical analysis showed that after intraintestinal SAF exposure, large amounts of PrP were present as CGI TSE transport by dendritic cells TSE transport by dendritic cells Fig. 2 . DCs transport intestinally injected SAF to mesenteric nodes via lymph. Lymph was collected 8 to 16 h after intestinal injection of SAF and strong cytoplasmic inclusions of PrP were detected by immunocytochemistry in a small proportion of DCs (a) but not B (b) or T (c) lymphocytes in the thoracic duct pseudo-lymph of mesenteric lymphadenectomized rats. Only endogenous PrP was detected in DCs from PBS-injected control animals (d). Magnification i1000. In all panels, PrP was detected using the PrP-specific polyclonal antiserum 1B3 (Farquhar et al., 1989) . conspicuous cytoplasmic inclusions in 4 to 5 % of lymph DCs (Fig. 2a) . No such deposits were identified within T or B lymphocyte populations (Fig. 2b, c, respectively) . Much weaker PrP staining was seen around lymph DCs (Fig. 2d) and B lymphocytes (data not shown) from PBS-treated controls, indicative of membrane-associated endogenously expressed rat PrP c . Immunoblot analysis confirmed the presence of detergent-insoluble, relatively proteinase K-resistant PrP Sc in lymph DC lysates selected from SAF-injected rats (Fig. 3, lane   4) . However, the characteristic molecular mass shift in the three-band PrP Sc signature after proteinase K digestion was not seen (Fig. 3, lane 6 ; Hope et al., 1986) . The multiple bands detected may indicate a difference in PrP processing either in the intestine or within DCs. No PrP was detected in lysates of T or B lymphocytes selected from SAF-injected rats (Fig. 3,  lanes 1, 2, respectively) . Neither was PrP detected in lysates from DCs, T or B lymphocytes from mesenteric lymphadenectomized rats treated with PBS or an SAF equivalent preparation from normal uninfected brain as a control (data not shown).
We next attempted to estimate scrapie infectivity levels in cell populations by animal bioassays. Pooled cell lysates were prepared from DCs, T lymphocytes or B lymphocytes from SAF-treated rats and injected intracerebrally into groups of 12 assay mice (approximately 2n5i10& cells per mouse). Despite the detection of PrP Sc in lymph DCs by immunoblot (Fig. 3) and immunocytochemical (Fig. 2a) analysis, infectivity levels were below the level detectable by bioassay. This most probably reflects the sensitivity of the assay given that only a small number of cells were available for injection per assay mouse. Of those, only a small subset of the DCs had acquired PrP Sc (approximately 1i10% cells per mouse). This small number of cells represents the maximum we could collect ; each assay mouse (usually 12 per group) receiving DCs from two cannulated rats. As infectivity bioassays are more sensitive than PrP immunoblots, the failure to detect scrapie infectivity in DC lysates despite positive detection of PrP Sc by immunoblot is most likely because greater numbers of cells were analysed in the immunoblot study (1i10' cells per lane). All other cell populations and concentrated cell-free lymph plasma (i75 using Microcon concentrators, Amicon) from SAFinjected rats were also negative.
In this study we show that DCs can acquire PrP Sc in vitro and that a small sub-population of migrating DCs can take up and transport PrP Sc from the gut lumen through the lymphatics to lymphoid tissue. We have also shown that the uptake of PrP Sc from the gut lumen is restricted to DCs, as no PrP Sc was detected in other lymph cells or cell-free lymph plasma. The small numbers of cells involved, perhaps in addition to partial intracellular degradative mechanisms, may explain the longer incubation periods, and reduced efficiency of infection, following oral exposure in comparison with other peripheral routes. Within lymphoid tissue FDCs play a critical role in the amplification of TSE infectivity outside the CNS (Brown et al., 1999 ; Mabbott et al., 2000a, b ; Montrasio et al., 2000) . Our findings suggest that following infection via the gastrointestinal tract, DCs act as a cellular bridge between the gut lumen and the lymphoid TSE replicative machinery.
Within the intestine, DCs have been described in the lamina propria (Maric et al., 1996) , and in Peyer's patches where they form a dense layer of cells in the subepithelial dome, just beneath the follicle-associated epithelium and in close contact with M cells (Kelsall & Strober, 1996) . Following oral challenge CGJ F.-P. Huang and others F.-P. Huang and others of rodents with scrapie, heavy pathological PrP accumulations are detected within cells of the follicle-associated epithelium with morphology consistent with M cells (Beekes & McBride, 2000) , which have the potential to transcytose infectivity in vitro (Heppner et al., 2001) . However, further studies are necessary to determine whether DCs acquire PrP Sc after it has been internalized by M cells, or by direct uptake across the mucosal epithelium as recently shown for the transport of apoptotic intestinal epithelial cells (Huang et al., 2000) or bacteria (Rescigno et al., 2001 ). In addition, our studies do not exclude the possibility of direct uptake into PrP-expressing enteric nerves (Shmakov et al., 2000) .
The detection of infectivity within lymphoid tissues (Bruce et al., 2001) and PrP accumulation upon FDCs of patients with vCJD (Hill et al., 1999) suggest that this disease shares a similar pathogenesis to rodent TSE models. Immunomodulation alters susceptibility to TSEs in rodent models (Mabbott et al., 1998) and gut inflammation markedly stimulates DC traffic from the intestine (MacPherson et al., 1995) . Our studies suggest that it will be important to investigate where TSEs are taken up in the human gastro-intestinal tract, and whether this can be exacerbated by inflammatory conditions that stimulate DC migration.
